Our group found that the protease inhibitor used in antiretroviral therapy for HIV infection, saquinavir (SQV), restores and further improves the overall activity of cathepsins in Mtb-infected macrophages and more specifically, that of cathepsin S [1]. The gene discussed is CTSS; the disease is HIV infectious disease.